iShares Neuroscience and Healthcare ETF (IBRN) Short Interest Ratio & Short Volume

Short interest is the volume of iShares Neuroscience and Healthcare ETF shares that have been sold short but have not yet been closed out or covered. As of July 15th, traders have sold 1,700 shares of IBRN short. Learn More on iShares Neuroscience and Healthcare ETF's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IBRN shares currently have a short interest ratio of 2.0. Learn More on iShares Neuroscience and Healthcare ETF's short interest ratio.

Here is how the short interest of companies compare to iShares Neuroscience and Healthcare ETF: iShares Breakthrough Environmental Solutions ETF (0.44%), First Trust Nasdaq Lux Digital Health Solutions ETF (0.40%), AdvisorShares Restaurant ETF (0.42%), Horizon Kinetics Energy and Remediation ETF (1.28%), Pacer BlueStar Digital Entertainment ETF (1.75%), Amplify Weight Loss Drug & Treatment ETF (0.08%), KraneShares 90% KWEB Defined Outcome Through January 2026 ETF (0.24%), ProShares Ultra Nasdaq Cloud Computing ETF (0.22%), Tema Luxury ETF (0.50%), NYLI Clean Oceans ETF (0.09%), and

As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($5.11 billion), Charter Communications, Inc. ($4.76 billion), Reddit Inc. ($2.84 billion), SoFi Technologies, Inc. ($2.79 billion), Seagate Technology Holdings PLC ($2.79 billion), Live Nation Entertainment, Inc. ($2.67 billion), Rocket Lab Corporation ($2.49 billion), AST SpaceMobile, Inc. ($2.12 billion), Moderna, Inc. ($2.09 billion), and Omnicom Group Inc. ($2.04 billion). View all of the most shorted stocks.

Short selling IBRN is an investing strategy that aims to generate trading profit from iShares Neuroscience and Healthcare ETF as its price is falling. IBRN shares are trading down $0.19 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for iShares Neuroscience and Healthcare ETF occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of IBRN, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IBRN, twice per month. The most recent reporting period available is July, 15 2025.